Anti-IgE Treatment with Oral Immunotherapy in Multifood Allergic Participants: Results of a Randomized, Double-blinded Control Trial

BACKGROUND: Despite progress in single food oral immunotherapy (OIT), there is little evidence concerning the safety and efficacy of treating individuals with multiple food (multifood) allergies. We conducted a pilot study testing whether anti-IgE (omalizumab) combined with multifood OIT benefitted...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Gastroenterol Hepatol
Main Authors: Andorf, Sandra, Purington, Natasha, Block, Whitney M., Long, Andrew J., Tupa, Dana, Brittain, Erica, Spergel, Amanda Rudman, Desai, Manisha, Galli, Stephen J., Nadeau, Kari C., Chinthrajah, R. Sharon
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944204/
https://ncbi.nlm.nih.gov/pubmed/29242014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(17)30392-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados